Brooke Olson

Brooke Olson

Auto-generated profile, based on publicly available information

Brooke Olson

University of Minnesota, Health Sciences Libraries, Minneapolis, MN

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in Access Microbiology
Verified
Journal Article
Open access
KBKristen Bastug
Kristen Bastug
Uzal UmarUzal Umar
Uzal Umar
BOBrooke Olson
Brooke Olson
TSTina Marye Slusher
Tina Marye Slusher
CFChristopher D. Faulk
Christopher D. Faulk
BTBeth Thielen
Beth Thielen
Background. Nanopore‐based sequencing by Oxford Nanopore Technologies (ONT) offers rapid, cost‐effective and portable sequencing. As an emerging technology, ONT must be evaluated for efficacy and practical application in both high‐ and low‐resource settings. This scoping review (SR) aimed to (1) describe how nanopore technology is used in Africa for surveillance and diagnosis of human infectious diseases, (2) describe how nanopore technology aids in the real-time detection of infectious pathogens in Africa and (3) identify challenges and opportunities for utilizing nanopore technology in Africa to study infectious diseases. Methods. This SR followed the Joanna Briggs Institute Reviewer’s Manual framework for SRs. English language studies published from 1 January 2008 to 30 April 2024 that used ONT on human specimens collected in Africa and targeted ≥1 microbial agent were included. Searches were performed in Embase, Medline, PubMed, CINAHL and the Cochrane Library. The protocol was publicly available on the Open Science Framework Bastug et al. (Nanopore Sequencing for Infectious Diseases Surveillance and Diagnostics in Africa: a Scoping Review 2024) prior to data collection. Two independent reviewers screened studies using Covidence, and data was extracted using a custom REDCap instrument. Descriptive statistics and data visualization were performed in Microsoft Excel. Results. One thousand one hundred sixty-two studies were identified and 93 (8%) underwent full-text review. The portable MinION Mk1B was the most common ONT device (65% of studies). Eighty-eight studies analysed specimens from a single African country. Of these, 45% were sequenced in the same country, 7% in a different African country and 11% in a non-African country, while 32% did not specify the location. Specimen types included direct patient specimens (62%) and cultured isolates (35%), or a combination of both. Blood, serum or plasma was most common (35%), followed by naso- or oropharyngeal specimens (27%). Forty-four studies used ONT during an active infectious disease outbreak, 25 of which studied severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Seventy-two studies used ONT for genomic surveillance of infectious pathogens or antibiotic resistance genes, and one study used ONT for a direct clinical application. African-affiliated authors were included as first, middle and last authors in 46% of studies, and 15% were published by entirely African-affiliated teams. Ten studies published information on workflow timeline, and five studies published the per-specimen cost. Conclusions. ONT can enable timely and affordable sequencing in African countries as demonstrated through a small number of studies that accomplished these goals individually. Most studies used ONT for genomic surveillance of pathogens or antimicrobial resistance genes, while only one study used ONT directly for a real-time clinical application. A small number of studies described a short interval between specimen collection and sequence result, supporting that clinical applications are possible. There is a need for improved reporting of ONT methodology including pipeline timelines, cost, use of barcoding, flow cell models and the use of negative controls. Publications that provide these details will enhance reproducibility and support the development of new studies using ONT for the diagnosis and surveillance of infectious diseases in low-resource settings.

17 March 2025
Verified
Preprint
Open access
KBKristen Bastug
Kristen Bastug
Uzal UmarUzal Umar
Uzal Umar
BOBrooke Olson
Brooke Olson
TSTina Marye Slusher
Tina Marye Slusher
CFChristopher D. Faulk
Christopher D. Faulk
BTBeth Thielen
Beth Thielen
Background: Nanopore‐based sequencing by Oxford Nanopore Technologies (ONT) offers rapid, cost‐effective, and portable sequencing. As an emerging technology, ONT must be evaluated for efficacy and practical application in both high‐ and low‐resource settings. This scoping review (SR) aimed to: 1) describe how nanopore technology is used in Africa for surveillance and diagnosis of human infectious diseases, 2) describe how nanopore technology aids in the real-time detection of infectious pathogens in Africa, and 3) identify challenges and opportunities for utilizing nanopore technology in Africa to study infectious diseases. Methods: This SR followed the Joanna Briggs Institute Reviewer’s Manual framework for SRs. English‐language studies published from January 1, 2008, to April 30, 2024 that used ONT on human specimens collected in Africa and targeted ≥1 microbial agent were included. Searches were performed in Embase, Medline, PubMed, CINAHL, and the Cochrane Library. The protocol was publicly available on the Open Science Framework (1) prior to data collection. Two independent reviewers screened studies using Covidence, and data was extracted using a custom REDCap instrument. Descriptive statistics and data visualization were performed in Microsoft Excel. Results: 1162 studies were identified and 93 (8%) underwent full-text review. The portable MinION Mk1B was the most common ONT device (65% of studies). Eighty-eight studies analyzed specimens from a single African country. Of these, 45% were sequenced in the same country, 7% in a different African Country, 11% in a non-African country, and 32% did not specify location. Specimen types included direct patient specimens (62%) and cultured isolates (35%), or a combination of both. Blood, serum, or plasma was most common (35%), followed by naso- or oropharyngeal specimens (27%). Forty-four studies used ONT during an active infectious diseases outbreak, 25 of which studied SARS-CoV-2. Seventy-two studies used ONT for genomic surveillance of infectious pathogens or antibiotic resistance genes, and one study used ONT for a direct clinical application. African-affiliated authors were included as first, middle, and last authors in 46% of studies, and 15% were published by entirely African-affiliated teams. Ten studies published information on workflow timeline and five studies published the per-specimen cost. Conclusions: ONT can enable timely and affordable sequencing in African countries as demonstrated through a small number of studies that accomplished these goals individually. Improved reporting of ONT-specific methodology is needed, including timelines, cost, barcoding, flow cell model, and the use of negative controls. Publications that provide these details will enhance reproducibility and support the development of new studies using ONT for the diagnosis and surveillance of infectious diseases in low resource settings.

1 August 2025 in Journal of the Medical Library Association
Verified
Journal Article
Open access
RGRyn Gagen
Ryn Gagen
BOBrooke Olson
Brooke Olson
MCMerete Christianson
Merete Christianson
NTNicole Theis-Mahon
Nicole Theis-Mahon
Background: Health science libraries have invested in virtual reality technology and spaces to support use of this technology for teaching, learning, and research. Virtual reality has many uses within health sciences education such as simulation, exploration and learning, and soft skills development. It can also be used to build empathy in health sciences students through applications that provide an immersive, first-person perspective. Case presentation: This case describes how a health sciences library and liaison librarians partnered with a course instructor to support a class utilizing the library’s virtual reality resources. Librarians were collaborators in the development of the class and facilitated class sessions in the Virtual Reality Studio. Class sessions utilized the Beatriz Lab by Embodied Labs to increase empathy in medical students who were interested in working with geriatric or Alzheimer’s patients. Conclusion: Liaison librarians support teaching and learning through a variety of tools and resources, including virtual reality. By partnering with instructors, librarians can use their instruction and collection knowledge to design and facilitate classes that are meaningful and interactive. Virtual reality applications provide another resource that librarians can incorporate into their course-integrated instruction sessions.

16 June 2025
Verified
Preprint
Open access
KBKristen Bastug
Kristen Bastug
Uzal UmarUzal Umar
Uzal Umar
BOBrooke Olson
Brooke Olson
TSTina Marye Slusher
Tina Marye Slusher
CFChristopher D. Faulk
Christopher D. Faulk
BTBeth Thielen
Beth Thielen
Background:Nanopore‐based sequencing by Oxford Nanopore Technologies (ONT) offers rapid, cost‐effective, and portable sequencing. As an emerging technology, ONT must be evaluated for efficacy and practical application in both high‐ and low‐resource settings. This scoping review (SR) aimed to: 1) describe how nanopore technology is used in Africa for surveillance and diagnosis of human infectious diseases, 2) describe how nanopore technology aids in the real-time detection of infectious pathogens in Africa, and 3) identify challenges and opportunities for utilizing nanopore technology in Africa to study infectious diseases. Methods: This SR followed the Joanna Briggs Institute Reviewer’s Manual framework for SRs. English‐language studies published from January 1, 2008, to April 30, 2024 that used ONT on human specimens collected in Africa and targeted ≥1 microbial agent were included. Searches were performed in Embase, Medline, PubMed, CINAHL, and the Cochrane Library. The protocol was publicly available on the Open Science Framework (1) prior to data collection. Two independent reviewers screened studies using Covidence, and data was extracted using a custom REDCap instrument. Descriptive statistics and data visualization were performed in Microsoft Excel. Results: 1162 studies were identified and 93 (8%) underwent full-text review. The portable MinION Mk1B was the most common ONT device (65% of studies). Eighty-eight studies analyzed specimens from a single African country. Of these, 45% were sequenced in the same country, 7% in a different African Country, 11% in a non-African country, and 32% did not specify location. Specimen types included direct patient specimens (62%) and cultured isolates (35%), or a combination of both. Blood, serum, or plasma was most common (35%), followed by naso- or oropharyngeal specimens (27%). Forty-four studies used ONT during an active infectious diseases outbreak, 25 of which studied SARS-CoV-2. Seventy-two studies used ONT for genomic surveillance of infectious pathogens or antibiotic resistance genes, and one study used ONT for a direct clinical application. African-affiliated authors were included as first, middle, and last authors in 46% of studies, and 15% were published by entirely African-affiliated teams. Ten studies published information on workflow timeline and five studies published the per-specimen cost. Conclusions: ONT can enable timely and affordable sequencing in African countries as demonstrated through a small number of studies that accomplished these goals individually. Most studies used ONT for genomic surveillance of pathogens or antimicrobial resistance genes, while only one study used ONT directly for a real-time clinical application. A small number of studies described a short interval between specimen collection and sequence result, supporting that clinical applications are possible. There is a need for improved reporting of ONT methodology including pipeline timelines, cost, use of barcoding, flow cell models, and the use of negative controls. Publications that provide these details will enhance reproducibility and support the development of new studies using ONT for the diagnosis and surveillance of infectious diseases in low resource settings.

9 September 2026 in Antimicrobial Stewardship & Healthcare Epidemiology
Verified
Journal Article
Open access
PDF file
NGNicholas Goodhope
Nicholas Goodhope
AKAnjum Kaka
Anjum Kaka
ALAdrienne Landsteiner
Adrienne Landsteiner
BOBrooke Olson
Brooke Olson
AGAmy Gravely
Amy Gravely
JAJonathan Alpern
Jonathan Alpern
Objective: Examine randomized-controlled trials (RCTs) that form the evidence basis for chlorhexidine to evaluate industry influence on trial outcomes and conclusions. Design: Cross-sectional study. Setting: RCTs in humans from January 2000 to March 2024 evaluating chlorhexidine for preventing healthcare-associated infections. Methods: We analyzed trials to determine if investigator conflicts of interest (COI) or industry funding were associated with favorable outcomes. Predictors were trial funding by a chlorhexidine manufacturer or reported investigator COI. Primary outcomes were primary result favoring chlorhexidine and/or conclusion favoring chlorhexidine. Results: Among 172 trials, industry funding (n = 44) was associated with the primary result (n = 30/44) favoring chlorhexidine (univariate analysis odds ratio (OR) 2.73 [95% CI 1.24–6.01, P = .01]; multivariate OR 2.85 [95% CI 1.15–7.02, P = .02]) and the conclusion (n = 33/44) favoring chlorhexidine (univariate OR 2.92 [95% CI 1.28–6.68, P = .01]; multivariate OR 3.25 [95% CI 1.24–8.54, P = .02]). Investigator COI (n = 28) was associated with the primary result (n = 20/28) favoring chlorhexidine (univariate analysis odds ratio 2.77 [95% CI 1.10–6.93, P = .03]; multivariate OR 2.36 [0.81–6.88; P = .10]) and the conclusion (n = 21/28) favoring chlorhexidine (univariate OR 2.40 [0.93–6.21, P = .07]; multivariate OR 2.32 [0.77–6.99; P = .12]), which was not statistically significant. Conclusion: Trials funded by chlorhexidine sponsors were more likely to report favorable outcomes compared to trials not funded by chlorhexidine sponsors, suggesting an industry bias that may have influenced these trials.

1 June 2026 in Neurology Open Access
Verified
Journal Article
Closed access
JMJennifer Michelle McKay
Jennifer Michelle McKay
MSMihad Semir
Mihad Semir
KGKatherine Giorgio
Katherine Giorgio
SSSanaz Sedaghat
Sanaz Sedaghat
BOBrooke Olson
Brooke Olson
BSBehnam Sabayan
Behnam Sabayan
Homelessness is associated with an increased risk of stroke, likely secondary to uncontrolled vascular risk factors and poor access to preventive care and chronic disease management. Its specific impact on acute stroke care and outcomes remains poorly understood. In this study, we conducted a systematic review and meta-analysis to summarize the available evidence. We searched PubMed, EMBASE, PsycINFO, Scopus, and Web of Science from 2000 to 2024 without language or geographical restrictions. Original observational studies of adults with acute stroke experiencing homelessness were included. Studies in animals and children, and studies without clear characterization of housing status and stroke outcomes were excluded. We compared post-stroke mortality, use of cerebrovascular diagnostics and therapeutics (including intravenous thrombolysis [IVT], mechanical thrombectomy, and vessel imaging), discharge destinations, and length of hospital stay between patients experiencing homelessness (PEH) and housed patients. We conducted a meta-analysis by pooling relative risk effect size. Titles and abstracts of 1,598 articles were screened by two independent reviewers, and 80 studies were selected for full-text review. Seven studies comprising 620,327 (86.5% male, 54.5 average age) PEH and 3,035,234 (52.7% male, 57.4 average age) housed patients were included in the systematic review. Studies included in the meta-analysis were conducted in the United States. All seven studies were rated as moderate to high quality. Pooled analysis did not reveal differences in in-hospital mortality between PEH and housed patients (risk ratio [RR]; 1.10 95% confidence interval [CI] 0.82-1.48). PEH with ischemic stroke were receiving IVT less frequently compared to housed individuals (RR 0.86, 95% CI 0.77-0.97). Two studies reported on discharge destinations, both indicating that PEH were more likely to be discharged to self-care or leave against medical advice. Patients experiencing homelessness with stroke were less likely to receive IVT and more often discharged without support. Further research is needed to identify long-term stroke outcomes and address disparities of post-stroke care to improve outcomes in PEH with stroke. Prospero (Registration No. CRD42024582119).